Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon

Treatment with interferon beta (IFN-β) induces the production of binding antibodies (BAbs) and neutralizing antibodies (NAbs) in patients with multiple sclerosis (MS). NAbs against IFN-β are associated with a loss of IFN-β bioactivity and decreased clinical efficacy of the drug. The objective of thi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zare, Nasrin, Zarkesh-Esfahani, Sayyed Hamid, Gharagozloo, Marjan, Shaygannejad, Vahid
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Academy of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3857378/
https://ncbi.nlm.nih.gov/pubmed/24339712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2013.28.12.1801
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares